The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Infectious Hepatitis C Virus Pseudo-particles Containing Functional E1–E2 Envelope Protein Complexes
Open accessAbstract
The study of hepatitis C virus (HCV), a major cause of chronic liver disease, has been hampered by the lack of a cell culture system supporting its replication. Here, we have successfully generated infectious pseudo-particles that were assembled by displaying unmodified and functional HCV glycoproteins onto retroviral and lentiviral core particles. The presence of a green fluorescent protein marker gene packaged within these HCV pseudo-particles allowed reliable and fast determination of infectivity mediated by the HCV glycoproteins. Primary hepatocytes as well as hepato-carcinoma cells were found to be the major targets of infection in vitro. High infectivity of the pseudo-particles required both E1 and E2 HCV glycoproteins, and was neutralized by sera from HCV-infected patients and by some anti-E2 monoclonal antibodies. In addition, these pseudo-particles allowed investigation of the role of putative HCV receptors. Although our results tend to confirm their involvement, they provide evidence that neither LDLr nor CD81 is sufficient to mediate HCV cell entry. Altogether, these studies indicate that these pseudo-particles may mimic the early infection steps of parental HCV and will be suitable for the development of much needed new antiviral therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996) · Science · doi:10.1126/science.272.5259.263 · Cited by 4,903
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line
Lohmann, V., Körner, F., Koch, J.-O., Herian, U., Theilmann, L., & Bartenschlager, R. (1999) · Science · doi:10.1126/science.285.5424.110 · Cited by 2,814
Binding of Hepatitis C Virus to CD81
Pileri, P., Uematsu, Y., Campagnoli, S., Galli, G., Falugi, F., Petracca, R., Weiner, A. J., Houghton, M., Rosa, D., Grandi, G., et al. (1998) · Science · doi:10.1126/science.282.5390.938 · Cited by 2,066
Efficient Initiation of HCV RNA Replication in Cell Culture
Blight, K. J., Kolykhalov, A. A., & Rice, C. M. (2000) · Science · doi:10.1126/science.290.5498.1972 · Cited by 1,412
The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus
Scarselli, E., Ansuini, H., Cerino, R., Roccasecca, R. M., Acali, S., Filocamo, G., Traboni, C., Nicosia, A., Cortese, R., & Vitelli, A. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf529 · Cited by 1,177
Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor
Agnello, V., Ábel, G., Elfahal, M., Knight, G. B., & Zhang, Q.-X. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12766 · Cited by 974
Global surveillance and control of hepatitis C
(1999) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.1999.6120139.x · Cited by 904
Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles
André, P., Komurian-Pradel, F., Deforges, S., Perret, M., Berland, J. L., Sodoyer, M., Pol, S., Bréchot, C., Paranhos-Baccalà, G., & Lotteau, V. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.6919-6928.2002 · Cited by 690
Replication of hepatitis C virus
Bartenschlager, R., & Lohmann, V. (2000) · Microbiology · doi:10.1099/0022-1317-81-7-1631 · Cited by 611
Synthesis, Assembly, and Processing of Viral Proteins
Swanstrom, R. I., & Wills, J. (1997) · Europe PMC (PubMed Central) · Cited by 518
Flint, M., Maidens, C., Loomis-Price, L. D., Shotton, C., Dubuisson, J., Monk, P., Higginbottom, A., Levy, S., & McKeating, J. A. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6235-6244.1999 · Cited by 469
Self-citationAn Effective AIDS Vaccine Based on Live Attenuated Vesicular Stomatitis Virus Recombinants
Rose, N. F., Marx, P. A., Luckay, A., Nixon, D. F., Moretto, W. J., Donahoe, S. M., Montefiori, D., Roberts, A., Buonocore, L., & Rose, J. K. (2001) · Cell · doi:10.1016/s0092-8674(01)00482-2 · Cited by 440
Global surveillance and control of hepatitis C
Lavanchy, D., Purcell, R. H., Hollinger, F. B., et al. (1999) · UCL Discovery (University College London) · Cited by 433
Dubuisson, J., Hsu, H. H., Cheung, R. C., Greenberg, H. B., Russell, D. G., & Rice, C. M. (1994) · Journal of Virology · doi:10.1128/jvi.68.10.6147-6160.1994 · Cited by 425
Self-citationHepatitis C Virus Structural Proteins Assemble into Viruslike Particles in Insect Cells
Baumert, T. F., Ito, S., Wong, D. T., & Liang, T. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.5.3827-3836.1998 · Cited by 397
Persistent and Transient Replication of Full-Length Hepatitis C Virus Genomes in Cell Culture
Pietschmann, T., Lohmann, V., Kaul, A., Krieger, N., Rinck, G., Rutter, G., Strand, D., & Bartenschlager, R. (2002) · Journal of Virology · doi:10.1128/jvi.76.8.4008-4021.2002 · Cited by 364
Low density lipoprotein receptor as a candidate receptor for hepatitis C virus
Monazahian, M., B�hme, I., Bonk, S., Koch, A., Scholz, C., Grethe, S., & Thomssen, R. (1999) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(199903)57:3<223::aid-jmv2>3.0.co;2-4 · Cited by 349
Sandrin, V., Boson, B., Salmon, P., Gay, W., Nègre, D., Le Grand, R., Trono, D., & Cosset, F.-L. (2002) · Blood · doi:10.1182/blood-2001-11-0042 · Cited by 305
Self-citationVirus receptors: binding, adhesion strengthening, and changes in viral structure
Haywood, A. M. (1994) · Journal of Virology · doi:10.1128/jvi.68.1.1-5.1994 · Cited by 276
Nègre, D., Mangeot, P.-E., Duisit, G., Blanchard, S., Vidalain, P.-O., Leissner, P., Winter, A.-J., Rabourdin-Combe, C., Mehtali, M., Moullier, P., et al. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301292 · Cited by 206
Self-citationOp De Beeck, A., Montserret, R., Duvet, S., Cocquerel, L., Cacan, R., Barberot, B., Le Maire, M., Penin, F., & Dubuisson, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003003200 · Cited by 165
Self-citationCharacterization of Pseudotype VSV Possessing HCV Envelope Proteins
Matsuura, Y., Tani, H., Suzuki, K., Kimura‐Someya, T., Suzuki, R., Aizaki, H., Ishii, K., Moriishi, K., Robison, C. S., Whitt, M. A., et al. (2001) · Virology · doi:10.1006/viro.2001.0971 · Cited by 160
Nguyen, T. H., Oberholzer, J., Birraux, J., Majno, P. E., Morel, P., & Trono, D. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0653 · Cited by 132
Folding, Assembly and Subcellular Localization of Hepatitis C Virus Glycoproteins
Dubuisson, J. (2000) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59605-6_7 · Cited by 124
Self-citationMaurice, M., Verhoeyen, E., Salmon, P., Trono, D., Russell, S. J., & Cosset, F. (2002) · Blood · doi:10.1182/blood.v99.7.2342 · Cited by 107
Self-citationMechanisms of enveloped virus entry into animal cells
Klasse, P. J., Bron, R., & Marsh, M. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00002-7 · Cited by 96
Wellnitz, S., Klumpp, B., Barth, H., Ito, S., Depla, E., Dubuisson, J., Blum, H. E., & Baumert, T. F. (2002) · Journal of Virology · doi:10.1128/jvi.76.3.1181-1193.2002 · Cited by 95
Self-citationPatel, A. H., Wood, J., Pénin, F., Dubuisson, J., & McKeating, J. A. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-12-2873 · Cited by 93
Self-citationSynthesis, Assembly, and Processing of Viral Proteins -- Retroviruses
Jm, C., Sh, H., & He, V. (1997) · Cited by 64
Lentiviral Vectors Derived from Simian Immunodeficiency Virus
Négre, D., Duisit, G., Mangeot, P.-E., Moullier, P., Darlix, J., & Cosset, F. (2002) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-56114-6_3 · Cited by 41
Self-citationAbe, A., Chen, S., Miyanohara, A., & Friedmann, T. (1998) · Journal of Virology · doi:10.1128/jvi.72.8.6356-6361.1998 · Cited by 35
Treatment of Hepatitis C and Anemia in Human Immunodeficiency Virus–Infected Patients
Dieterich, D. T. (2002) · The Journal of Infectious Diseases · doi:10.1086/340199 · Cited by 35
Su, L. (1997) · Reviews in Medical Virology · doi:10.1002/(sici)1099-1654(199709)7:3<167::aid-rmv199>3.0.co;2-k · Cited by 7
(1982) · PubMed
Cited by
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., Murthy, K., Habermann, A., Kräusslich, H.-G., Mizokami, M., et al. (2005) · Nature Medicine · doi:10.1038/nm1268 · Cited by 2,754
Robust hepatitis C virus infection in vitro
Zhong, J., Gastaminza, P., Cheng, G., Kapadia, S., Kato, T., Burton, D. R., Wieland, S. F., Uprichard, S. L., Wakita, T., & Chisari, F. V. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503596102 · Cited by 1,709
Immunology of hepatitis B virus and hepatitis C virus infection
Rehermann, B., & Nascimbeni, M. (2005) · Nature Reviews Immunology · doi:10.1038/nri1573 · Cited by 1,627
Metadata
- Authors
- Bartosch, B., Dubuisson, J., & Cosset, F.-L.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2003-03-03
- Volume
- 197
- Issue
- 5
- Pages
- 633-642
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2110842901
- Cited by
- 1,111
- References
- 36
- FWCI
- 37.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.